Form 8.3 - Willis Towers Watson plc - Amendment

LONDON--()-- 

Ap19

FORM 8.3 - Amendment to Sales

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 25 June 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security:

ORD

 

 

Long

Short

Number

(%)

Number

(%)

(1)

Relevant securities

 

 

 

 

1,820,841

1.41%

240,483

0.19%

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

72,359

0.06%

202,408

0.16%

 

 

 

 

(3)

Options and agreements to

 

 

 

 

purchase/sell:

6,100

0.00%

6,100

0.00%

 

 

 

 

TOTAL:

 

 

 

 

1,899,300

1.47%

448,991

0.35%

 

 

 

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale

Number of relevant securities

Price per unit
Purchase

1

236.0900 USD
Purchase

2

235.5300 USD
Purchase

2

236.4900 USD
Purchase

2

236.0800 USD
Purchase

3

236.0566 USD
Purchase

4

236.0700 USD
Purchase

4

235.6300 USD
Purchase

4

235.8350 USD
Purchase

4

235.1100 USD
Purchase

6

236.2233 USD
Purchase

6

234.6000 USD
Purchase

16

234.7750 USD
Purchase

19

236.1400 USD
Purchase

26

235.4600 USD
Purchase

55

235.1550 USD
Purchase

82

232.9150 USD
Purchase

85

235.3141 USD
Purchase

100

235.7100 USD
Purchase

100

236.1108 USD
Purchase

100

235.9900 USD
Purchase

214

235.6294 USD
Purchase

268

235.5236 USD
Purchase

268

235.5235 USD
Purchase

298

235.3513 USD
Purchase

377

234.7901 USD
Purchase

600

235.3917 USD
Purchase

767

233.9590 USD
Purchase

1,673

234.9408 USD
Purchase

2,507

235.6969 USD
Purchase

2,720

235.6143 USD
Purchase

4,924

235.5000 USD
Purchase

5,863

235.1417 USD
Purchase

7,549

235.1803 USD
Purchase

8,265

235.3055 USD
Purchase

10,047

235.0017 USD
Purchase

10,163

235.1415 USD
Purchase

10,517

235.4823 USD
Purchase

10,924

235.1597 USD
Purchase

19,609

235.2011 USD
Sale

2

232.5700 USD
Sale

2

236.4900 USD
Sale

6

234.6000 USD
Sale

8

234.4400 USD
Sale

12

235.4600 USD
Sale

21

235.5957 USD
Sale

37

235.2900 USD
Sale

37

236.0554 USD
Sale

37

236.0200 USD
Sale

37

235.4050 USD
Sale

47

235.6614 USD
Sale

57

235.9182 USD
Sale

64

234.7556 USD
Sale

74

235.8279 USD
Sale

86

235.8638 USD
Sale

100

234.9100 USD
Sale

100

235.3600 USD
Sale

100

236.2500 USD
Sale

111

236.0933 USD
Sale

111

236.1725 USD
Sale

119

235.6972 USD
Sale

126

235.5795 USD
Sale

130

234.1992 USD
Sale

160

235.5487 USD
Sale

190

233.8047 USD
Sale

200

236.4100 USD
Sale

213

235.5986 USD
Sale

223

235.7564 USD
Sale

268

235.5235 USD
Sale

339

235.5007 USD
Sale

340

234.6513 USD
Sale

397

235.2422 USD
Sale

500

236.1776 USD
Sale

762

235.4987 USD
Sale

1,000

235.7418 USD
Sale

1,100

235.7663 USD
Sale

1,105

235.5338 USD
Sale

1,243

234.8809 USD
Sale

1,545

234.7935 USD
Sale

1,705

235.5321 USD
Sale

1,887

235.5154 USD
Sale

2,218

234.8040 USD
Sale

2,577

235.4763 USD
Sale

2,932

235.6400 USD
Sale

3,067

235.1244 USD
Sale

3,100

235.5151 USD
Sale

3,834

235.5000 USD
Sale

5,000

235.0428 USD
Sale

5,608

234.9388 USD
Sale

5,612

234.8219 USD
Sale

7,383

235.3506 USD
Sale

9,108

235.0777 USD
Sale

10,517

235.4823 USD
Sale

10,810

235.2063 USD
Sale

12,422

235.0807 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure:

29 Jun 2021

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

 

Category Code: RET
Sequence Number: 740404
Time of Receipt (offset from UTC): 20210629T112849+0100

Contacts

BARCLAYS PLC

Contacts

BARCLAYS PLC